An ACCP International Symposium
Held in conjunction with the 26th Order of Pharmacists of Lebanon Annual Congress
November 16, 2018 | 8:45 a.m. to 5:30 p.m.
Hilton Habtoor Grand Hotel
Beirut, Lebanon
Target Audience
The symposium is designed for pharmacists and pharmacy trainees caring for patients with cardiovascular diseases in all practice settings.
Symposium Goal
The symposium will discuss recent updates to guidelines for the management of common chronic and acute cardiovascular diseases and analyze findings from key practice-changing clinical trials that advance healthcare. Sessions will employ case-based learning to engage participants in activities that enable them to translate published evidence into daily practice and improve outcomes associated with patient care services.
Symposium Learning Objectives
At the conclusion of the symposium, the participant should be able to:
- Apply current guidelines and recent clinical trial evidence for managing hypertension, dyslipidemia, and heart failure.
- Provide evidence-based, individualized recommendations for therapy with antithrombotic agents.
- Recommend optimal strategies for the pharmacological management of patients presenting with acute coronary syndrome.
- Devise outcome measures to assess, document, and advance the quality and cost-effectiveness of patient care services provided by pharmacists.
Agenda
8:45 a.m. |
Welcome and Introductions |
9:00 a.m. |
Clinical Guidelines: Updates in Hypertension, Dyslipidemia, and Heart Failure |
11:00 a.m. |
Coffee Break |
11:30 a.m. |
Antithrombotic Agents: Clinical Evidence and Agent Selection |
1:30 p.m. |
Lunch |
3:00 p.m. |
Acute Coronary Syndrome: Optimal Pharmacotherapy Strategies |
4:30 p.m. |
Coffee Break |
5:00 p.m. |
Measuring Outcomes Associated with Pharmacist Services |
5:30 p.m. |
Closing Remarks |
Session Learning Objectives
Clinical Guidelines: Updates in Hypertension, Dyslipidemia, and Heart Failure
At the conclusion of the session, the participant should be able to:
- Develop a guideline-based treatment plan for patients with hypertension, dyslipidemia, and heart failure.
- Recognize the limitations of recent trials in patients with hypertension, dyslipidemia, and heart failure in developing individualized treatment plans.
- Devise suitable monitoring plans to ensure safe use of medications in patients with hypertension, dyslipidemia, and heart failure.
Antithrombotic Agents: Clinical Evidence and Agent Selection
At the conclusion of the session, the participant should be able to:
- Differentiate between common chronic antithrombotic agents used in the management of patients with atrial fibrillation, and patients with ischemic heart disease.
- Recommend an individualized treatment plan to reduce stroke in patients with atrial fibrillation.
- Determine a suitable antithrombotic regimen for patients with stable ischemic heart disease.
Acute Coronary Syndrome: Optimal Pharmacotherapy Strategies
At the conclusion of the session, the participant should be able to:
- Develop an acute treatment plan for a patient presenting with acute coronary syndromes.
- Choose a suitable antithrombotic regimen for patients with acute coronary syndromes.
- Create a secondary prevention plan after an acute coronary syndrome.
Measuring Outcomes Associated with Pharmacist Services
At the conclusion of the session, the participant should be able to:
- Ascertain target cardiac conditions which may benefit from pharmacist services.
- Identify potential measures for examining pharmacist services in cardiology.
- Develop an outline for a program to measure the quality of outcomes associated with pharmacist services in cardiology.
Symposium Moderator
Wafa Y. Dahdal, Pharm.D.
Director of International Programs &
Associate Director of Professional Development
American College of Clinical Pharmacy
Program Faculty
Cynthia Jackevicius, BScPhm, PharmD, MSc, APh, BCPS-AQ Cardiology, FCSHP, FAHA, FCCP, FCCS
Professor & Director, Cardiovascular Outcomes Research Fellowship
College of Pharmacy, Western University of Health Sciences
Clinical Pharmacy Specialist, Cardiology, VA Greater Los Angeles Healthcare System
Senior Adjunct Scientist, Institute for Clinical Evaluative Sciences
Associate Professor, Institute for Health Policy, Management & Evaluation, University of Toronto
Faculty Disclosures
Dr. Dahdal and Dr. Jackevicius have no relevant affiliations or financial relationships with commercial interest to disclose.
Certificates of Attendance
Certificates of attendance will be granted to participants attending the entire symposium.
Student Registration and Fees
Student registration and payment received before:
|
Fee*
|
October 15, 2018 |
$ 99 |
November 15, 2018 |
$114 |
Onsite registration |
$124 |
*Registration fee includes program book, a certificate of attendance, and two coffee breaks.
Cancellation Policy:
- Registration cancellations for the ACCP International Symposium must be notified in writing, by email to ACCP at [email protected].
- Cancellations received on or before October 15, 2018 will be refunded the registration fees, less an administration charge of $50.
- Cancellations made after October 15, 2018 and no shows are not eligible for a refund.
- Refunds will be processed 4 weeks after the event completion date.
Commercial Support
No commercial support has been received for this activity.
Travel and Accommodations
Information on travel and accommodations is available here.
Please address questions about the 2018 ACCP International Symposium to [email protected].